首页> 外文期刊>Journal of Medicinal Chemistry >Computational analysis of PKA-balanol interactions.
【24h】

Computational analysis of PKA-balanol interactions.

机译:PKA-balanol相互作用的计算分析。

获取原文
获取原文并翻译 | 示例
           

摘要

Protein kinases are important targets for designing therapeutic drugs. This paper illustrates a computational approach to extend the usefulness of a single protein-inhibitor structure in aiding the design of protein kinase inhibitors. Using the complex structure of the catalytic subunit of PKA (cPKA) and balanol as a guide, we have analyzed and compared the distribution of amino acid types near the protein-ligand interface for nearly 400 kinases. This analysis has identified a number of sites that are more variable in amino acid types among the kinases analyzed, and these are useful sites to consider in designing specific protein kinase inhibitors. On the other hand, we have found kinases whose protein-ligand interfaces are similar to that of the cPKA-balanol complex and balanol can be a useful lead compound for developing effective inhibitors for these kinases. Generally, this approach can help us discover new drug targets for an existing class of compounds that have already been well characterized pharmacologically. The relative significance of the charge/polarity of residues at the protein-ligand interface has been quantified by carrying out computational sensitivity analysis in which the charge/polarity of an atom or functional group was turned off/on, and the resulting effects on binding affinity have been examined. The binding affinity was estimated by using an implicit-solvent model in which the electrostatic contributions were obtained by solving the Poisson equation and the hydrophobic effects were accounted for by using surface-area dependent terms. The same sensitivity analysis approach was applied to the ligand balanol to develop a pharmacophoric model for searching new drug leads from small-molecule libraries. To help evaluate the binding affinity of designed inhibitors before they are made, we have developed a semiempirical approach to improve the predictive reliability of the implicit-solvent binding model.
机译:蛋白激酶是设计治疗药物的重要靶标。本文说明了一种计算方法,可扩展单个蛋白抑制剂结构在辅助蛋白激酶抑制剂设计中的实用性。以PKA(cPKA)和Balanol催化亚基的复杂结构为指导,我们分析并比较了近400种激酶在蛋白质-配体界面附近的氨基酸类型分布。这项分析已经确定了许多位点,这些位点在所分析的激酶中的氨基酸类型上变化更大,这些是设计特定蛋白激酶抑制剂时需要考虑的有用位点。另一方面,我们发现了蛋白-配体界面与cPKA-balanol复合物相似的激酶,而balanol可能是开发这些激酶有效抑制剂的有用先导化合物。通常,这种方法可以帮助我们发现已经通过药理学很好地表征的现有化合物的新药物靶标。通过进行计算灵敏度分析,可以关闭/打开原子或官能团的电荷/极性,并对结合亲和力产生影响,从而对蛋白质-配体界面上残基的电荷/极性的相对重要性进行了定量。已经检查过了。通过使用隐式溶剂模型来估计结合亲和力,其中通过求解泊松方程获得静电贡献,并通过使用表面积相关的项来考虑疏水效应。将相同的敏感性分析方法应用于配体Balanol,以开发药效学模型,以从小分子文库中搜索新的药物线索。为了帮助评估设计的抑制剂在制备前的结合亲和力,我们开发了一种半经验方法来提高隐式溶剂结合模型的预测可靠性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号